Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?-Reference-Cited by-同舟云学术

Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?

Published:2013-05 Issue:5 Volume:43 Page:599-603
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Nikpour M.¹²,Stevens W.²,Proudman S. M.³,Buchbinder R.⁴⁵,Prior D.¹⁶,Zochling J.⁷,Williams T.⁸,Gabbay E.⁹,Nandurkar H.¹¹⁰

Affiliation:

1. Department of Medicine; St Vincent's Academic Centre; The University of Melbourne; Melbourne Victoria Australia

2. Department of Rheumatology; St Vincent's Hospital Melbourne; Melbourne Victoria Australia

3. Discipline of Medicine; University of Adelaide; Rheumatology Unit; Royal Adelaide Hospital; Adelaide South Australia Australia

4. Monash Department of Clinical Epidemiology; Cabrini Hospital; Melbourne Victoria Australia

5. Department of Epidemiology and Preventive Medicine; School of Public Health and Preventive Medicine; Monash University; Melbourne Victoria Australia

6. Department of Cardiology; St Vincent's Hospital Melbourne; Melbourne Victoria Australia

7. The Menzies Research Institute; Hobart Tasmania Australia

8. Department of Allergy, Immunology and Respiratory Medicine; Monash University; Melbourne Victoria Australia

9. Advanced Lung Disease Unit; Royal Perth Hospital; Perth Western Australia Australia

10. Hematology; St Vincent's Hospital Melbourne; Melbourne Victoria Australia

Funder

a University of Melbourne Faculty of Medicine, Dentistry and Health Sciences David Bickart Clinician Researcher Fellowship

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12111/fullpdf

Reference35 articles.

1. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China;Mok;Arthritis Rheum,2011

2. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies;Elhai;Rheumatology (Oxford),2012

3. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies;Komocsi;Rheumatology (Oxford),2012

4. Mortality and cause of death in an Australian systemic sclerosis cohort;Nikpour;Ann Rheum Dis,2011

5. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database;Tyndall;Ann Rheum Dis,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is anticoagulative therapy in systemic sclerosis to be reconsidered?;Journal of Scleroderma and Related Disorders;2024-06

2. A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis;Clinical and Experimental Medicine;2023-11-01

3. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival;Arthritis Research & Therapy;2022-05-10

4. ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM;Eurasian heart journal;2017-12-30

5. Patient with Hypertension and Right Ventricular Enlargement;Practical Case Studies in Hypertension Management;2017